Blessing receives national cancer grant
QUINCY (WGEM) - Blessing Health officials say they will be better equipped to serve patients with advanced cases of colorectal cancer after getting a national grant.
The hospital announced Monday they received $99,500 from Pfizer Global Medical Grants and the Association of Community Cancer Centers.
The money will be used to improve processes that contribute to the ordering of advanced testing, known as biomarker testing, for patients with metastatic colorectal cancer.
The advanced testing is expected to lead to more targeted treatments with fewer side effects.
“It’s going to be a way for us to standardize operating procedures internally to approach patient care in a way that can optimize treatments for this niche metastatic colorectal cancer patient population,” clinical research director Kiley McGlauchlen said.
Officials said the results of the project are expected to triple the number of metastatic colorectal cancer patients getting biomarker testing over the next two years at the Blessing Cancer Center.
But McGlauchlen said the project will benefit all cancer patients.
“Ultimately this will be important work that will go forward because it will be sustainable so everything we’re doing in this patient population will really apply to all various diagnoses of cancer that we see and treat here at the Blessing Cancer Center,” she said.
Blessing said colorectal cancer is the third-leading cause of cancer death in the United States.
Copyright 2021 WGEM. All rights reserved.